View All Blog Posts

High Vaccine Confidence Among Patients in Malaysia

Over the past year, biopharmaceutical companies have worked at an unprecedented speed to research and develop COVID-19 vaccines, treatments and diagnostics – supported by the innovation ecosystem along the way. As regulatory authorities continue to monitor the safety and efficacy of these innovations and authorize them for public use, it is important for patients to also feel confident in and accept inoculation once vaccine supply is available.

The Vaccine Confidence Project recently reported that Malaysia ranks high in the Vaccine Confidence Index with 91% of its population reporting they are confident in the safety and efficacy of vaccines. According to researchers at the University Putra Malaysia, driving factors include trust in public health care services and providers, as well as high vaccine risk-benefit-awareness and health-seeking behavior. This confidence is evident in the success of various vaccination programs conducted by Malaysia’s Ministry of Health.

To continue growing confidence among its public, Malaysian government officials should support decisions made by the National Pharmaceutical Regulatory Agency (NPRA) and allow the agency to practice vigilance with every review. Empowering communities through strong and transparent communications that are backed by science will also be important, as misinformation continues to threaten public confidence.

All COVID-19 vaccines follow a rigorous process for scientific evaluation like vaccines for other diseases. And each vaccine is carefully tested with tens of thousands of people. Clinical trial results are reviewed by independent experts prior to approval for use with the public.

Malaysia’s high vaccine confidence must not be taken for granted. As COVID-19 vaccine distribution ramps up, it is crucial for people to continue to feel confident in the safety and efficacy of the vaccine and decide to get vaccinated for the betterment of their health and those around them. The eradication of COVID-19 depends on it.

Recent Blog Posts

EU Commission Cites Systemic IP Barriers in Southeast Asia

Strong intellectual property (IP) protection and enforcement is critical to helping countries attract foreign investment, promote economic growth, provide greater access to medicines and improve patient outcomes. The biennial “Report on the Protection and Enforcement of Intellectual Property Rights in Third Countries” cites Malaysia, Indonesia and Thailand as priority countries that will need to strengthen their IP regulations to stay globally competitive.

IP Protections Help Improve Cancer Screening and Prevention in Malaysia

Cervical cancer is the third most common cancer in women in Malaysia, but the country’s screening rate is disproportionately low. Intellectual property protections are helping to pave the way for a new program to improve screening rates and prevention in Malaysia.